European Journal of Cancer
Volume 41, Issue 13 , Pages 1969-1979 , September 2005

Mechanisms and preclinical efficacy of silibinin in preventing skin cancer

  • Rana P. Singh

      Affiliations

    • Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, 4200 East Ninth Avenue, Box C238, Denver, CO 80262, United States
    • ,
  • Rajesh Agarwal

      Affiliations

    • Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, 4200 East Ninth Avenue, Box C238, Denver, CO 80262, United States
    • University of Colorado Cancer Center, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 303 315 1381; fax: +1 303 315 6281.

Received 2 March 2005 ,Revised 10 March 2005 ,Accepted 18 March 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(05)00474-0

doi: 10.1016/j.ejca.2005.03.033

European Journal of Cancer
Volume 41, Issue 13 , Pages 1969-1979 , September 2005

Article Tools

* Image Usage & Resolution